Department of Cardiology, Jiangxi Provincial People's Hospital, No. 92 Aiguo Road, Donghu District, Nanchang, 330006, Jiangxi Province, China.
Department of Graduate School, Medical College of Nanchang University, No. 461 Bayi Avenue, Donghu District, Nanchang, 330006, Jiangxi Province, China.
Lipids Health Dis. 2020 Jun 20;19(1):145. doi: 10.1186/s12944-020-01326-3.
Fasting plasma glucose (FPG) is an easily quantifiable and inexpensive metabolic marker, which is often used to assess cardiovascular disease and diabetes. However, there have been limited studies on the association between FPG and nonalcoholic fatty liver disease (NAFLD) risk in nonobese people, especially in Chinese individuals. The purpose of this study was to investigate the association between FPG and NAFLD in nonobese Chinese people with normal blood lipid levels.
In this prospective cohort study, 9767 nonobese participants with normal blood lipid levels without NAFLD were recruited and prospectively followed for 5 years. The Cox proportional hazard model was used to evaluate the risk factors of NAFLD. Moreover, a Cox model with cubic spline functions and smooth curve fitting (the cubic spline smoothing) were used to identify the nonlinear association between FPG and NAFLD.
During the 5-year follow-up, 841 (8.61%) participants were diagnosed with NAFLD. The good functional results (without NAFLD) estimated by the Kaplan-Meier method for 1 year, 2 years, 3 years, 4 years, and 5 years were 98.84, 95.35, 91.67%, 87.57 and 74.86%, respectively. Additionally, through the Cox proportional hazard model, after adjusting for other covariates, there was an independent positive correlation between FPG and increased NAFLD risk (HR:1.21, 95% CI:1.15-1.28, P < 0.0001), and the NAFLD risk was incrementally higher with the rising FPG quartile. The nonlinear association between FPG and NAFLD was visualized by cubic spline smoothing technique. It was calculated that the inflection point of FPG was 5.54. When FPG ≤ 5.54, there was a positive correlation between FPG and the risk of NAFLD (HR:2.20, 95% CI:1.78-2.73, P < 0.0001). When FPG > 5.54, the risk of NAFLD increased by 50% (HR:1.10, 95% CI:1.02-1.18, P = 0.0159) compared with the left side of the inflection point and gradually leveled off.
In a nonobese Chinese population with normal lipid levels, there is an independent nonlinear association between FPG and NAFLD, and the increase in FPG may indicate an increased risk of NAFLD. Additionally, this independent association is more obvious in the short stature population.
空腹血糖(FPG)是一种易于量化且价格低廉的代谢标志物,常用于评估心血管疾病和糖尿病。然而,在非肥胖人群中,特别是在中国人群中,关于 FPG 与非酒精性脂肪性肝病(NAFLD)风险之间关联的研究有限。本研究旨在探讨非肥胖、血脂正常的中国人中 FPG 与 NAFLD 之间的关系。
在这项前瞻性队列研究中,纳入了 9767 名非肥胖、血脂正常且无 NAFLD 的参与者,并前瞻性随访 5 年。采用 Cox 比例风险模型评估 NAFLD 的危险因素。此外,采用 Cox 模型中的三次样条函数和光滑曲线拟合(三次样条平滑)来确定 FPG 与 NAFLD 之间的非线性关系。
在 5 年的随访期间,841 名(8.61%)参与者被诊断为 NAFLD。Kaplan-Meier 法估计的 1 年、2 年、3 年、4 年和 5 年无 NAFLD 的良好功能结果分别为 98.84%、95.35%、91.67%、87.57%和 74.86%。此外,通过 Cox 比例风险模型,在调整其他协变量后,FPG 与 NAFLD 风险的增加呈独立的正相关(HR:1.21,95%CI:1.15-1.28,P<0.0001),并且随着 FPG 四分位的升高,NAFLD 风险逐渐升高。三次样条平滑技术可视化了 FPG 与 NAFLD 之间的非线性关系。计算得出 FPG 的拐点为 5.54。当 FPG≤5.54 时,FPG 与 NAFLD 风险之间呈正相关(HR:2.20,95%CI:1.78-2.73,P<0.0001)。当 FPG>5.54 时,NAFLD 的风险比拐点左侧增加 50%(HR:1.10,95%CI:1.02-1.18,P=0.0159),并且逐渐趋于平稳。
在血脂正常的非肥胖中国人群中,FPG 与 NAFLD 之间存在独立的非线性关联,FPG 的升高可能预示着 NAFLD 风险的增加。此外,这种独立的关联在身材矮小的人群中更为明显。